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When platelets are stimulated by thrombin they immediately undergo mositol lipid hydrolyses via phosphohpase C activatton. However, subse- 
quently an increased production of phosphattdylinositol4,5-bisphosphate is observed. Phosphohpases C were inhtbited by lowering the cytoplasmtc 
free calcium concentration by preincubation with Quin-2-tetra(acetoxymethy1) ester. Aggregation and secretion were also totally suppressed. Under 
these condittons we observed an increased labeling of phosphatidylinositol 4.5-btsphosphate, indicating a stimulatton of inositol liptd kinases, 
independent of lipid hydrolysis by phospholipase C. Conversely the productton of phosphatidyhnosttol 3.4-bisphosphate was totally abolished. 
These results suggest a different regulation of the kinases/phosphatases responsible for the production of phosphattdylinositol 4.5-bisphosphate 
and phosphattdylinositol 3.4-bisphosphate. 
Phosphoinositide kinase; Phosphoinosittde turnover: Calctum chelator 
1. INTRODUCTION 
It has been shown that when platelets, like many 
other cells, are stimulated, they undergo a hydrolysis of 
inositol lipids by one or more phospholipases C, and 
display a stimulation of inositol lipid phosphorylation, 
leading to an increase of PtdIns4P and PtdIns4,5Pz [ 1.21 
and to the production of PtdIns3,4P2 [335]. The action 
of the phospholipases C is well known to produce in- 
creases of calcium via inositol trisphosphate release and 
protein kinase C activation due to the production of 
diacylglycerol, but little is known about the role of the 
increases of PtdInsP,. However, some data indicate that 
the amounts of PtdIns4,5Pz are susceptible to regulating 
actin polymerisation [6,7], therefore modulating the 
shape change and/or thrombus retraction. It has been 
postulated that the reported increases of PtdInsP, (and 
to some extent of PtdInsP) are due to a ‘withdrawal 
effect’ [S] elicited by the hydrolysis of the end-product 
of a chain of kinases and phosphatases. Such a hydrol- 
ysis was then supposed to be responsible for the com- 
pensating activation of these kinases and inhibition of 
*Corresponding author. Fax: (33) (61) 31 97 52 
Abbrevrations: PtdIns. phosphattdylinosttol: Ptdlns4.5Pz. phosphati- 
dylinositol 4,5_btsphosphate; Quin-Z/AM. Quin-2_tetra(acetoxyme- 
thy]) ester; PtdIns4PS-kinase, phosphatidylinositol4-monophosphate 
5-kinase; PtdOH, phosphatidic acid; DMSO. dimethyl-sulfoxyde. 
phosphatases. Another possibility is that thrombin 
binding is, by itself, able to stimulate the kinases (or 
inhibit the phosphatases). Indeed in some cells the stim- 
ulation of receptors by their agonists has been described 
to directly affect the inositol lipid kinases as well as 
other kinases [9]. Such a mechanism encompasses the 
binding of inositol lipid kinases to a complex formed by 
the receptor itself or some other proteins, such as 
pp60”~“” or polyoma virus middle T antigen, and other 
regulating proteins. So far this kind of association has 
been described for receptors with intrinsic tyrosine ki- 
nase activity, i.e. the platelet-derived growth factor [9]. 
When stimulated by thrombin, platelets indeed display 
an increase in tyrosine phosphorylation of a full set of 
proteins [lo, 111. One part of these phosphorylations 
appears to be dependent upon aggregation [12,13] like 
the major part of the PtdIns3,4P, production [14]. Until 
now, no data were available on the regulation of PtdIns 
4-kinase nor PtdIns4P 5-kinase in platelets. Despite the 
possible importance of tyrosine phosphorylation. the 
link between thrombin receptor occupancy and this reg- 
ulating event is totally missing, even if platelets contain 
exceptionally large amounts of a putative tyrosine ki- 
nase ~~60’.““, as well as other non-receptor tyrosine 
kinases. However, the structure of the thrombin recep- 
tor casts some doubt on its ability to be an intrinsic 
protein tyrosine kinase [15]. It would be of interest to 
determine if thrombin is, nevertheless, able to induce an 
activation of the phosphorylation of inositol lipids, in- 
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dependently of any other sign of platelet activation, i.e. 37°C for 2 min Incubation was carried on for the indicated periods 
phospholipase C activation, secretion or aggregation. of time. under shakmg. 
To test the hypothesis of a direct action of thrombin 
on the phosphorylation of inositol lipids we took advan- 
tage of the ability of Quin-2 to chelate, with high affin- 
ity, cytosolic free calcium. Under these conditions we 
demonstrated that thrombin was still able to induce a 
slight but reproducible increase in the phosphorylation 
cascade producing PtdInP, but did no longer stimulate 
PtdInsP, hydrolysis as judged from the inhibition of 
PtdOH production. Interestingly, PtdIns3PPz was not 
produced at all upon thrombin addition, in contrast to 
our previous data showing only a 60% reduction when 
aggregation was inhibited [14]. 
Lipid extraction, which served also to quench the reactions, was 
according to a modification of the method of Bhgh and Dyer [lS] as 
described previously [5]. The analysis of the extracts was performed 
on silicagel G plates (Merck, Darmstadt, Germany) previously 
sprayed with 1% potassium oxalate. The elution solvent was chloro- 
fo~/methanol/acetone/acetic acid/water, 80,26:24: 16 (v/v) as de- 
scribed by Jolles et al. [19]. Determmatlon of radloactivlty of the 
different spots was performed by liquid scintillation counting after 
autoradiography. In some instances the analysis was performed after 
methylamine hydrolysis of the lipids. Deacylated extracts were then 
analysed by HPLC on a Partisphere SAX column 150 x 4.6 mm 
(Whatman, Maiden Head. England) with a O--l M ammonium phos- 
phate buffer gradient [VO]. 
2. MATERIALS AND METHODS 
2.1. Platelet prepurutm 
Platelet preparation was as described previously [16] as modified [5] 
for the labeling of cells wrth [“Pjorthophosphate (100 ~Uc~lrnl m the 
first washing fluid, for 2 h at room temperature) Blood donors were 
informed volunteers. stating that they were free of drugs for the last 
ten days (Centre RCgional de Transfusion Sanguine. Toulouse, 
France). 
In some experiments platelet lysls was evaluated by lactate dehydro- 
genase liberation [21] and [Ca”], measured by spectrofluorimetry [i7]. 
The platelet release reaction was checked by N-acetyl$-D-glucosam- 
inidase [22] and [“Clserotonm appearance in the supernatants. Aggre- 
gation was checked by turbidimetry (231. 
3. RESULTS 
Quin-2iAM incorporation was as described by Simon et al. [17]. 
Quin-Z/AM (up to 200 PM) m DMSO or DMSO alone was added to 
the already 3’P-labeled platelet suspensions in calcium-free Tyrode’s 
buffer (135 mM NaCl, 2.7 mM KCI, 11.9 mM NaHCO,, 0.36 mM 
NaHZPO,, 1 mM MgCZ, 5.5 mM glucose, 0.34% bovine serum albu- 
min, pH 6.5). Incubations were for 30 min at room temperature. The 
final amount of DMSO was 1% of the total volume. 
Thrombin activation of the platelets was obtained by adding 1 NIH 
unit of human thrombin (Sigma, Saint-Louis. MO, USA) per ml of 
suspension (7 x 10’ platelets/ml m Tyrode’s buffer, without added 
calcium except where it is mentioned, pH 7.4). already warmed at 
3.1. Efffeet of Qu~~~~~~~ M on ~ro~lbin-i~d~~~d release 
We checked that 30 min preincubation with 100 or 
200 ,uM Quin-YAM did not lyse the platelets (Table I). 
This treatment inhibited the aggregation induced by 1 
NIH unit thrombi~ml, in a calcium-free Tyrode’s 
buffer, by almost 100% at all the times tested (O-300 s). 
This treatment also inhibited the dense granule secre- 
tion and lysosomal release by more than 80% as judged 
by [“Clserotonin or ~-acetyl-~-D-glucosaminidase se- 
cretion (Table I). Addition of calcium in the extracellu- 
lar medium partially reversed this inhibitory effect on 
platelet secretion at 30 s of thrombin stimulation. More- 
Table I 
Consequences of a piatelet loading by high concentrations of Qum-Z/AM on mtracelluiar calcium level, cell lysis, serotonm reiease and PtdOH 
production: reverslblhty of these effects by addition of calcium to the extracellular medium 
Quin-Z/AM 
luM) 
CaClz 
(mM) 
Lysis 
(%) 
Release 
(%i 
[“‘P]PtdOH 
(%) 
0 0 1.8 rt 0.1 72.0 + 4.4 100 
0 2.5 68.0 + 1.0 112 
DMSO 1% 0 0.6 + 0.6 67.0 t 3.6 84.6 ? 11.5 
DMSO 1% 2.5 1.8 I: 0.1 73.0 * 2.3 93.8 ? 25 6 
100 0 37 1.2 t 0.6 10.0 + 1.9 2.0 + 2.0 
100 2.5 269 1.1 + 0.6 36.0 + 1.2 79.0 + 27.5 
200 0 so 2.4 + 0.7 11.0 * 0.9 7.7 + 6.3 
200 2.5 173 18+0.1 30.0 t 4.7 99.0 + 27.7 
Platelets were incubated with 100 or 200 ,uM of Quin-UAM (DMSO as carrier) then resuspended in the final buffer with or without 2.5 mM of 
calcium as indicated m section 2. [Ca”], and cell lys~s were estimated m resting platelets while serotonm release and PtdOH production were 
measured after 30 s of thrombin stimulation (1 NIH U/ml) as described in section 2. Results are means + S.E.M. of three independent experiments 
except for [Ca”], data which are representahve of two independent experiments and for PtdOH level in the absence of Quin-Z/AM but with 
2.5 mM of calcium in the extraceilular medium (n = 1). 
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Fig. 1. Effect of increasing Qum-Z/AM concentration on the produc- 
tion of PtdOH in thrombin-stimulated platelets. “P-labeled platelets 
were incubated with amounts of Quin-2/AM as indicated. After stim- 
ulation by 1 NIH unit thrombin/ml for the indicated periods, lipids 
were extracted and separated by thin-layer chromatography as de- 
scribed in section 2. Results are representative of 1 (Qum-2/AM = 75 
PM) or 2 independent experiments (mean + S.D.) and are the relative 
amounts of radioactivity present in the PtdOH spot, radioactivity at 
time 0 being taken as 100. 
over, the presence of calcium in the extracellular me- 
dium provoked an increase of the intracellular calcium 
level in resting Quin-loaded platelets (Table I). These 
results argue in favor of the viability of cells preloaded 
by 100 or 200 ,uM of Quin-2lAM. 
3.2. Blockade of the activation of the phospholipase C
When platelets were incubated with increasing 
amounts of Quin-Z/AM, a progressive inhibition of the 
production of PtdOH elicited by 1 NIH unit thrombin/ 
ml was obtained (Fig. 1). Concentrations as high as 100 
,uM were needed for a total inhibition of the PtdOH 
production during the time of experimentation (40 s). 
Preincubations with 100 PM Quin-2/AM were therefore 
chosen for the following experiments since it is generally 
believed that PtdOH production is a good indicator of 
the activity of phospholipase C. However, 200 PM Quin 
were used when evaluating the effect of calcium deple- 
tion on thrombin-induced PtdIns3,4P, production, 
since the incubation time was then 300 s. In some exper- 
iments, 100 PM Quin-Z/AM were uneffective in totally 
blocking the production of PtdOH at 300 s. The effect 
of Quin-2/AM on the phospholipase C activity could be 
reversed by addition of calcium in the activation buffer 
(Table I). This suggests that inhibition of PtdOH produc- 
tion was not due to non specific effects of the calcium 
chelator or to byproducts, such as formaldehyde, re- 
leased upon hydrolysis of Quin-2lAM. 
3.3. Effect of Quin-2IAM on the basal metabolism of 
inositol lipids 
We wanted to explore the inositol lipid metabolism 
in resting platelets preincubated with 200 ,uM of Quin- 
2/AM. Analysis of the [32P]phospholipids by HPLC 
showed no significant changes of the 32P incorporation 
into inositol lipids, particularly in the case of the 
PtdIns4,5Pz which varied from 42.5 ? 0.6 in the absence 
of Quin-2 to 43.4 + 0.6 with Quin-2 (data are the per- 
centages of the total radioactive lipids, mean & SD., 
n = 3). The total radioactivity in Quin-2/AM treated 
platelets was 110 & 23% of that in control cells. 
3.4. Time course of inositol lipid labeling upon thrombin 
stimulation 
When control platelets were challenged with 1 NIH 
unit thrombin/ml, we obtained the classical appearance 
of PtdOH and a transient decrease of PtdInsP, (Fig. 2). 
However, this was not still true when Quin-2-loaded 
platelets were challenged under the same conditions. 
Indeed, as already mentioned, PtdOH production was 
abolished and the metabolism of PtdInsP, was very 
different. As it can be seen in Fig. 2, instead of a de- 
crease of the labeling of PtdInsP,, obtained in control 
cells, an increase of the 32P incorporation was observed 
and lasted for 20 s in Quin-2-treated platelets. This 
significant increase accounted for 11% by comparison 
with the basal level. Experiments prolonged after 60 s 
of thrombin activation showed no variation in the radio- 
activity of [“P]PtdIns4,5P, at later periods (results not 
shown). HPLC analysis of the deacylated lipids (Fig. 3) 
revealed that no PtdIns3,4P2 was produced, at any time, 
up to 300 s, while a maximal labeling was obtained for 
control platelets, as already reported [5]. The increase 
of labeling of PtdInsP,, as observed by TLC, was then 
exclusively due to an increase of [32P]tdIns4,5P2. During 
the same period the labeling of PtdIns4P was not signif- 
icantly altered by Quin-2 loading (Fig. 2). [32P]PtdIns 
did not decrease as it was observed in control platelets, 
which is consistent with an inhibition of the phospholip- 
ase(s) C (Fig. 2). 
4. DISCUSSION 
The data reported above reveal that, when the hy- 
drolysis of inositol lipids was impaired, thrombin was 
able to specifically increase the labeling of 
[3’P]PtdIns4,5P, in platelets. This suggests an action of 
the thrombin receptor on the PtdIns phosphorylation 
equilibrium, in a manner independent of the ‘with- 
drawal’ hypothesis. The conditions used in our experi- 
ments are close to those of other authors [17,24,25] 
who used the buffering capacity of Quin-2 to modulate 
the calcium levels in the cytosol. According to Johnson 
et al. [26], the external Quin-2/AM concentration is di- 
rectly proportional to the final cytosolic Quin-2 concen- 
tration and under our conditions, 100 ,uM or 200 PM 
external Quin-2/AM the intracellular Quin-2 concentra- 
tion should be about 10 or 20 mM, respectively. Lew et 
al. [25] demonstrated that 100 ,uM of Quin-2/AM has 
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Fig. 2. Time course of radioactive inosltol lipids and PtdOH production by platelets challenged with thrombm (1 NIH umt/ml) m the presence 
or absence of Quin-YAM. Platelets were Incubated 4’1th (closed cncles) or wlthout (open circles) Quin-‘/AM as indicated m section 2 and then 
stimulated with thrombm for the mdlcated times. [“P]Llplds were extracted and quantified after thm-layer chromatography. Results are 
means k S.D. of 10 Independent experiments. Data are expressed as relative amounts of radloactl\ity present in correspondent lipld species from 
platelets before stimulation. Student’s t-test (unpaired) gave probabilities of the observed means to be ldentlcal as Indicated. *P < 0.05. **P < 0.01. 
****p < 0 001. 
a specific effect on the neutrophil metabolism, with 
maintenance of the ATP level and without influence of 
the formaldehyde formed. Under our experimental con- 
ditions, the free calcium concentration has been lowered 
to sub-resting levels. Under these stringent calcium- 
poor conditions, we succeeded in abolishing all the pro- 
duction of PtdOH, from which we infer that the phos- 
pholipase(s) C were inactive. 
The stimulation of PtdIns4,5P, labeling is generally 
believed to reveal an increase in the mass of the lipid 
since 90 min preincubation of the platelets with “POJH, 
has been shown to label the phosphomonoesters at equi- 
librium with the y phosphate of ATP [27]. However, a 
precise determination of the mass is needed for the cor- 
rect understanding of variations of phosphorylated lip- 
ids in living cells. Unfortunately. we were unable to 
measure the slight variations of mass by determination 
of phosphorus by calorimetry. Nevertheless we can as- 
sume, as it is classically admitted. that the equilibrium 
between PtdIns4P kinase and PtdIns4,5Pz phosphatase 
as well as that between Ptdlns kinase and PtdIns4P 
phosphatase are shifted in such a manner that the mass 
of PtdIns4,5P, is increased. We cannot infer from our 
data if the actual enzymes affected by thrombin stimula- 
tion are kinases (then stimulated) or phosphatases (in- 
hibited). However, the indication of an increase of 
PtdIns4,5P, is an argument for a direct effect of throm- 
bin on inositol lipid metabolism. As far as we can infer 
from what is known on transmembrane receptors, it 
seems that the thrombin receptor recently cloned [ 151 is 
350 
of a type believed to interact directly with G proteins 
and not to belong to the tyrosine kinase receptor family. 
This would imply that a relay molecule is needed to 
activate inositol lipid metabolism. The increase is ob- 
served early (up to 20 s after addition of maximal doses 
of thrombin), therefore the machinery between the 
thrombin receptor and the kinase and/or phosphatase 
should be fast enough. It is interesting to note the result 
of Urumow and Wieland [28], showing the involvement 
of a small unidentified G protein in the regulation of rat 
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Fig. 3. Effect of Qum-Z/AM on PtdIns3,4P2 productlon in thrombin- 
stimulated platelets. Platelets were incubated with 200 ,uM Qum- 
2/ AM. then stimulated by I NIH umt thrombm/ml. After extrac- 
tion, radIoactIve phosphohpids were deacylated and submitted to 
HPLC as described m sectlon 2 Results are means 2 S.E.M. of 2 in- 
dependent experiments. 
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liver plasma membrane PtdIns4P kinase activity. On 
the other hand, it is also of interest to know that the 
PtdIns3,4P, production, recently described in platelets, 
is a late event [3-51 while the effect reported here is an 
early one. Usually it is believed that PtdIns3,4P, pro- 
duction is due to the activation of a PtdIns4P 3-kinase 
by a tyrosine protein kinase, which is itself activated as 
a consequence of aggregation [12-141. However, re- 
cently the role of protein kinase C has also been demon- 
strated [29]. The total inhibition of PtdIns3,4P, produc- 
tion by Quin-2 could not be totally explained by the 
total lack of aggregation obtained under these circum- 
stances. This inhibition is of a much greater amplitude 
than that obtained previously with the tetrapeptide 
RGDS, or even with Glanzmann’s thrombasthenic pa- 
tients who totally failed to aggregate to thrombin [14]. 
It is not known if any of the reported inositol lipid 
3-kinases are calcium sensitive, and one should test the 
hypothesis of a more central mechanism for this inhibi- 
tion. For instance it is quite obvious that protein kinase 
C is strongly inhibited by simultaneous calcium chela- 
tion and lack of diacylglycerol production. 
A report by Lassing and Lindberg [30] already dem- 
onstrated that, at very early times of stimulation by 
small amounts of thrombin, a slight increase of 
PtdIns4,5P3 could be observed, very transiently, just 
before the classical decrease of the lipid, due to phos- 
pholipase C action. Besides confirming this previous 
observation, our present data exclude the possibility 
that the increase of PtdIns4,5P, could occur in response 
to phospholipase C activation (‘withdrawal effect’ hy- 
pothesis). On the other hand, the work of Steen et al. 
[31] has shown a strong correlation between the 3’P 
incorporation into PtdIns4P and PtdIns4,5P, and the 
PtdOH production upon thrombin stimulation in plate- 
lets, even though they only explored the 90th second of 
thrombin stimulation. Therefore, our results and those 
of Lassing and Lindberg [30] on the one hand, and the 
results of Perret et al. [I], Mauco et al. [2] and Steen et 
al. [31] on the other, argue in favor of two steps in the 
PtdIns4,5P, synthesis. The first rapid step could be de- 
pendent directly on thrombin receptor activation. The 
second slower step (after the first min of thrombin acti- 
vation) could be regulated by the phospholipase C/pro- 
tein kinase C pathway. The possible existence of differ- 
ent pools of PtdIns4,5P, in platelets remain to be ex- 
plored, which could be synthesized by different 
PtdIns4P 5-kinase isoforms, and have different func- 
tions. Perhaps, for the precocious pool of PtdIns4,5P, 
synthesized, a role in the regulation of the cytoskeleton 
organization as evoked by Lassing and Lindberg [30] 
could be proposed. 
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